Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

One-Day Protocol for Imaging of the Nigrostriatal Dopaminergic Pathway in Parkinson's Disease by [123I]FPCIT SPECT

Jan Booij, Jos T.G.M. Hemelaar, Johannes D. Speelman, Kora de Bruin, Anton G.M. Janssen and Eric A. van Royen
Journal of Nuclear Medicine May 1999, 40 (5) 753-761;
Jan Booij
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jos T.G.M. Hemelaar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes D. Speelman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kora de Bruin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anton G.M. Janssen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric A. van Royen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 40, Issue 5
May 1, 1999
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
One-Day Protocol for Imaging of the Nigrostriatal Dopaminergic Pathway in Parkinson's Disease by [123I]FPCIT SPECT
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
One-Day Protocol for Imaging of the Nigrostriatal Dopaminergic Pathway in Parkinson's Disease by [123I]FPCIT SPECT
Jan Booij, Jos T.G.M. Hemelaar, Johannes D. Speelman, Kora de Bruin, Anton G.M. Janssen, Eric A. van Royen
Journal of Nuclear Medicine May 1999, 40 (5) 753-761;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
One-Day Protocol for Imaging of the Nigrostriatal Dopaminergic Pathway in Parkinson's Disease by [123I]FPCIT SPECT
Jan Booij, Jos T.G.M. Hemelaar, Johannes D. Speelman, Kora de Bruin, Anton G.M. Janssen, Eric A. van Royen
Journal of Nuclear Medicine May 1999, 40 (5) 753-761;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Role of Functional Dopamine-Transporter SPECT Imaging in Parkinsonian Syndromes, Part 1
  • Acute Administration of Haloperidol Does Not Influence 123I-FP-CIT Binding to the Dopamine Transporter
  • (123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study
  • Assessing the Optimal Time Point for the Measurement of Extrastriatal Serotonin Transporter Binding with 123I-FP-CIT SPECT in Healthy, Male Subjects
  • Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study
  • SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0
  • Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies
  • Validation of a Standardized Normalization Template for Statistical Parametric Mapping Analysis of 123I-FP-CIT Images
  • Quantification of Striatal Dopamine Transporters with 123I-FP-CIT SPECT Is Influenced by the Selective Serotonin Reuptake Inhibitor Paroxetine: A Double-Blind, Placebo-Controlled, Crossover Study in Healthy Control Subjects
  • Pharmacological Characterization of (E)-N-(4-Fluorobut-2-enyl)-2beta-carbomethoxy-3beta-(4'-tolyl)nortropane (LBT-999) as a Highly Promising Fluorinated Ligand for the Dopamine Transporter
  • Quantification of 123I-PE2I Binding to Dopamine Transporter with SPECT After Bolus and Bolus/Infusion
  • [123I]FP-CIT SPECT findings in two patients with Hallervorden-Spatz disease with homozygous mutation in PANK2 gene
  • Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease
  • The harsh realities facing the use of SPECT imaging in monitoring disease progression in Parkinson's disease
  • Dosimetry of the Dopamine Transporter Radioligand 18F-FPCIT in Human Subjects
  • Investigating Dopaminergic Neurotransmission with 123I-FP-CIT SPECT: Comparability of Modern SPECT Systems
  • Google Scholar

More in this TOC Section

  • Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies
  • Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
  • Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers
Show more Clinical Investigation

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire